A recently published review article, originally covered by our sister brand Cannabis Science and Technology, discussed a study about testing for inaccuracies in hemp-derived cannabidiol (CBD) products.
Read the original piece from Cannabis Science and Technology here.
Image © adobestock.com/brillianataImage © adobestock.com/brillianata
A recent study found that a high percentage of various types of hemp-derived cannabidiol (CBD) products contained inaccurate claims on their labels. The 97 products tested in this study consisted of haircare and cosmetic items, food, drinks, and edibles that were purchased in 2020 in Maryland from both retail stores and online. All the products’ labels claimed they contained CBD or specified amounts of CBD that the product contained.
Using gas chromatography-mass spectrometry (GC-MS), the researchers measured the cannabinoid concentration of each product, compared it to the advertised amount, and measured the deviation.
Overall, most of the labels were found to contain inaccurate information regarding CBD content. In particular, 10 products were determined to not contain any CBD.
Some of the other results included (1):
The products tested included ones that stated claims for third-party testing, though the accuracy of CBD content did not differ significantly between products with and without external testing claims.
“Many products made therapeutic claims or used marketing tactics to seemingly convey they were safe/healthy, but only about one-third included disclaimers that these statements had not been evaluated by the FDA,” the researchers also concluded. “These findings highlight the need for proper regulatory oversight of cannabinoid-containing products to ensure quality assurance and deter misleading or unfounded health claims in product marketing.”
(1) Dowd, A. N.; Zamarripa, C. A.; Sholler, D. J.; Cone, E. J.; Murphy, T. P.; ElSohly, M.; ElSohly, K.; Gul, W.; Shahzadi, I.; Mullen, L. D.; Winecker, R. E.; Flegel, R. R.; Vandrey, R.; Spindle, T. R. Cannabinoid Content and Label Accuracy of Various Hemp-Derived Haircare, Cosmetic, and Edible Products Available at Retail Stores and Online in the United States. Cannabis and Cannabinoid Research 2024. Advance online publication. DOI: 10.1089/can.2024.0039
Navigating the Impact of Funding Cuts: Voices from the Research Community
July 9th 2025Shifts in U.S. federal science funding—driven by the newly established Department of Government Efficiency (DOGE)—are causing delays, uncertainty, and program changes across academic and regulatory research institutions.
FDA Grants Breakthrough Status to AI-Enhanced GC-MS Device for Bladder Cancer Detection
July 1st 2025A new cancer detection test to analyze volatile organic compounds through urine analysis, was granted the Breakthrough Device Designation status by the U.S. FDA. The system, which is built on gas chromatography–mass spectrometry (GC–MS) and proprietary AI, generates real-time cancer risk scores.